Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation
Close
Home
Company
About
Leadership
Careers
Pipeline
Development Pipeline
Targeted Therapeutics
Systemic Therapeutics
Publications
Investors
Investor Overview
Press Releases
Events & Presentations
SEC Filings
Annual & Quarterly Reports
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Governance Documents
Committee Composition
Investor FAQs
Investor Email Alerts
Investor Relations Contact
Contact
Toggle the search bar
Search the Site
Close the mobile navigation
Publications
Select Category
Select Category...
Gastrointestinal Health
Systemic Therapeutics
Targeted Therapeutics
Targeted topical anti-α4β7 integrin antibody results in reduced accumulation of α4β7 memory T-cells in gut tissue in DSS-induced colitis mice
October 28, 2019
#Targeted Therapeutics
Revolutionary GI diagnostics and therapeutics are on the horizon
October 28, 2019
#Gastrointestinal Health
Proof-of-concept data on new ingestible technologies
May 17, 2019
#Gastrointestinal Health
1
2
3
Connect with us
Email Us
Biora Therapeutics Linkedin
Biora Therapeutics Twitter